<DOC>
	<DOCNO>NCT00802139</DOCNO>
	<brief_summary>multi-center , prospective , randomize , open-labeled , active-drug-controlled , two-parallel-group-comparison ( venoferrun group vs Bolgre group ) study</brief_summary>
	<brief_title>Efficacy Safety Study Iron Sucrose Oral Iron Acetyl-transferrin Hydroglycerin</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>30~32nd week pregnant woman age 18 year Women Hb level 10.0g/dL week study initiation Patients agree participate study write Patients participate another clinical study recent 3 month Patients prone acute hemorrhage pregnancy Patients show intolerance iron therapy Hemolytic anemia , hemoglobinopathy ( thalassemia , sickle cell ) Bleeding tendency , hypersplenism Chronic heart failure , Class IIIV heart disease , uncontrolled arterial hypertension ( DBP â‰¥ 115mmHg ) , deep vein thrombosis , thrombocytosis , chronic renal disease Severe renal failure patient ( 2.5 time higher plasma creatinine level high limit normal state ) Patients severe liver dysfunction ( 2.5 time higher AST ALT high limit normal state ) Patients double CK level high limit normal state Patients regard ineligible study investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>iron deficiency anemia</keyword>
	<keyword>pregnant woman iron deficiency anemia</keyword>
</DOC>